 | • レポートコード：QY20ST-07178 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器・消耗品 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の末梢インターベンション薬物溶出デバイス市場について種類別（プレーンオールドバルーン血管形成術（POBA）、経皮経管的血管形成術（PTA））、用途別（薬剤溶出バルーン、薬剤溶出ステント）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・末梢インターベンション薬物溶出デバイス市場の概要 ・世界の主要地域別末梢インターベンション薬物溶出デバイス市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の末梢インターベンション薬物溶出デバイス市場規模2015-2026：種類別（プレーンオールドバルーン血管形成術（POBA）、経皮経管的血管形成術（PTA）） ・世界の末梢インターベンション薬物溶出デバイス市場規模2015-2026：用途別（薬剤溶出バルーン、薬剤溶出ステント） ・末梢インターベンション薬物溶出デバイスの北米市場規模2015-2020 ・末梢インターベンション薬物溶出デバイスのヨーロッパ市場規模2015-2020 ・末梢インターベンション薬物溶出デバイスの中国市場規模2015-2020 ・末梢インターベンション薬物溶出デバイスの日本市場規模2015-2020 ・末梢インターベンション薬物溶出デバイスの東南アジア市場規模2015-2020 ・末梢インターベンション薬物溶出デバイスのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・末梢インターベンション薬物溶出デバイスの製造コスト分析 ・販売チャネル、流通業者、顧客 ・末梢インターベンション薬物溶出デバイスの市場動向・機会・課題 ・調査の結論 |
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
Market Analysis and Insights: Global Peripheral Intervention Drug-Eluting Devices Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Peripheral Intervention Drug-Eluting Devices market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Peripheral Intervention Drug-Eluting Devices industry.
Based on our recent survey, we have several different scenarios about the Peripheral Intervention Drug-Eluting Devices YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Peripheral Intervention Drug-Eluting Devices will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Peripheral Intervention Drug-Eluting Devices Scope and Market Size
The global Peripheral Intervention Drug-Eluting Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Intervention Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Peripheral Intervention Drug-Eluting Devices market is segmented into
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Segment by Application, the Peripheral Intervention Drug-Eluting Devices market is segmented into
Drug-Eluting Balloons
Drug-Eluting Stents
The Peripheral Intervention Drug-Eluting Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Peripheral Intervention Drug-Eluting Devices market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peripheral Intervention Drug-Eluting Devices Market Share Analysis
Peripheral Intervention Drug-Eluting Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peripheral Intervention Drug-Eluting Devices business, the date to enter into the Peripheral Intervention Drug-Eluting Devices market, Peripheral Intervention Drug-Eluting Devices product introduction, recent developments, etc.
The major vendors covered:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Product Scope
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2020-2026)
1.2.2 Plain Old Balloon Angioplasty (POBA)
1.2.3 Percutaneous Transluminal Angioplasty (PTA)
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Comparison by Application (2020-2026)
1.3.2 Drug-Eluting Balloons
1.3.3 Drug-Eluting Stents
1.4 Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts (2015-2026)
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2026)
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2015-2026)
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
1.5.1 How the Covid-19 is Affecting the Peripheral Intervention Drug-Eluting Devices Industry
1.5.1.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
2 Peripheral Intervention Drug-Eluting Devices Estimate and Forecast by Region
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2015-2020)
2.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
2.3 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.2 Europe Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.3 China Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.4 Japan Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.6 India Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
3 Global Peripheral Intervention Drug-Eluting Devices Competition Landscape by Players
3.1 Global Top Peripheral Intervention Drug-Eluting Devices Players by Sales (2015-2020)
3.2 Global Top Peripheral Intervention Drug-Eluting Devices Players by Revenue (2015-2020)
3.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)
3.4 Global Peripheral Intervention Drug-Eluting Devices Average Price by Company (2015-2020)
3.5 Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)
4 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Type (2015-2020)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2014-2020)
4.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
5 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Application (2015-2020)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2015-2020)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2015-2020)
5.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2021-2026)
3 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
3.2 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
3.3 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
3.4 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
4 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
4.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.4 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
5 China Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
5.2 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
5.3 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
5.4 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
6 Japan Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
6.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
6.3 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
6.4 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
7 Southeast Asia Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
7.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
8 India Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
8.2 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
8.3 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
8.4 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Peripheral Intervention Drug-Eluting Devices Business
12.1 Medtronic plc
12.1.1 Medtronic plc Peripheral Intervention Drug-Eluting Devices Corporation Information
12.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
12.1.5 Medtronic plc Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.2.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.2.5 Boston Scientific Corporation Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Corporation Information
12.3.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Cardinal Health
12.4.1 Cardinal Health Peripheral Intervention Drug-Eluting Devices Corporation Information
12.4.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered
12.4.5 Cardinal Health Recent Development
12.5 B. Braun Melsungen AG
12.5.1 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Corporation Information
12.5.2 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered
12.5.5 B. Braun Melsungen AG Recent Development
12.6 Biosensors International Group Ltd.
12.6.1 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Corporation Information
12.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered
12.6.5 Biosensors International Group Ltd. Recent Development
12.7 C.R. Bard, Inc.
12.7.1 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Corporation Information
12.7.2 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered
12.7.5 C.R. Bard, Inc. Recent Development
12.8 Abbott
12.8.1 Abbott Peripheral Intervention Drug-Eluting Devices Corporation Information
12.8.2 Abbott Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered
12.8.5 Abbott Recent Development
12.9 The Lubrizol Corporation
12.9.1 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.9.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.9.5 The Lubrizol Corporation Recent Development
12.10 Terumo Corporation
12.10.1 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.10.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.10.5 Terumo Corporation Recent Development
13 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis
13.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
13.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peripheral Intervention Drug-Eluting Devices Distributors List
14.3 Peripheral Intervention Drug-Eluting Devices Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Peripheral Intervention Drug-Eluting Devices Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Peripheral Intervention Drug-Eluting Devices Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
Table 8. Global Market Peripheral Intervention Drug-Eluting Devices Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Region (2015-2020)
Table 10. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2015-2020)
Table 11. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Region (2015-2020)
Table 13. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Peripheral Intervention Drug-Eluting Devices Revenue Share Forecast by Region (2021-2026)
Table 17. Global Peripheral Intervention Drug-Eluting Devices (K Units) of Key Companies (2015-2020)
Table 18. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Company (2015-2020)
Table 19. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Company (2015-2020)
Table 21. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)
Table 22. Global Peripheral Intervention Drug-Eluting Devices Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites and Area Served
Table 24. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Peripheral Intervention Drug-Eluting Devices Players
Table 27. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 28. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2015-2020)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Peripheral Intervention Drug-Eluting Devices Price (K Units) by Type (2015-2020)
Table 31. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2021-2026)
Table 32. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2021-2026)
Table 34. Global Peripheral Intervention Drug-Eluting Devices Price (K Units) by Type (2021-2026)
Table 35. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 36. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2015-2020)
Table 37. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Peripheral Intervention Drug-Eluting Devices Price (K Units) by Application (2015-2020)
Table 39. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2021-2026)
Table 40. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2021-2026)
Table 41. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2021-2026)
Table 43. Global Peripheral Intervention Drug-Eluting Devices Price (K Units) by Application (2021-2026)
Table 44. United States Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 45. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 46. United States Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 47. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 48. United States Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 49. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 50. Europe Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 51. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 52. Europe Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 53. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 54. Europe Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 55. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 56. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 57. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 58. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 59. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 60. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 61. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 62. Japan Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 63. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 64. Japan Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 65. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 66. Japan Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 67. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 74. India Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 75. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 76. India Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 77. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 78. India Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 79. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 80. Medtronic plc Corporation Information
Table 81. Medtronic plc Description and Business Overview
Table 82. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product
Table 84. Medtronic plc Recent Development
Table 85. Boston Scientific Corporation Corporation Information
Table 86. Boston Scientific Corporation Description and Business Overview
Table 87. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 89. Boston Scientific Corporation Recent Development
Table 90. Abbott Laboratories Corporation Information
Table 91. Abbott Laboratories Description and Business Overview
Table 92. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product
Table 94. Abbott Laboratories Recent Development
Table 95. Cardinal Health Corporation Information
Table 96. Cardinal Health Description and Business Overview
Table 97. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product
Table 99. Cardinal Health Recent Development
Table 100. B. Braun Melsungen AG Corporation Information
Table 101. B. Braun Melsungen AG Description and Business Overview
Table 102. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product
Table 104. B. Braun Melsungen AG Recent Development
Table 105. Biosensors International Group Ltd. Corporation Information
Table 106. Biosensors International Group Ltd. Description and Business Overview
Table 107. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product
Table 109. Biosensors International Group Ltd. Recent Development
Table 110. C.R. Bard, Inc. Corporation Information
Table 111. C.R. Bard, Inc. Description and Business Overview
Table 112. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product
Table 114. C.R. Bard, Inc. Recent Development
Table 115. Abbott Corporation Information
Table 116. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Abbott Description and Business Overview
Table 118. Abbott Peripheral Intervention Drug-Eluting Devices Product
Table 119. Abbott Recent Development
Table 120. The Lubrizol Corporation Corporation Information
Table 121. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. The Lubrizol Corporation Description and Business Overview
Table 123. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 124. The Lubrizol Corporation Recent Development
Table . Terumo Corporation Corporation Information
Table . Terumo Corporation Description and Business Overview
Table . Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product
Table . Terumo Corporation Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 133. Peripheral Intervention Drug-Eluting Devices Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2020 & 2026
Figure 6. Drug-Eluting Balloons Examples
Figure 7. Drug-Eluting Stents Examples
Figure 8. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Peripheral Intervention Drug-Eluting Devices Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Peripheral Intervention Drug-Eluting Devices Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue in Peripheral Intervention Drug-Eluting Devices 2015 & 2019
Figure 26. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2015-2020)
Figure 28. Global Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2015-2020)
Figure 30. Global Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 32. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 33. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 34. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 35. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 36. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 37. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 38. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 39. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 40. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 41. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 42. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 43. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 44. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 45. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 46. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 47. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 48. Medtronic plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. B. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Biosensors International Group Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. C.R. Bard, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. The Lubrizol Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Terumo Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Peripheral Intervention Drug-Eluting Devices
Figure 60. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
Figure 61. Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
末梢動脈疾患用薬剤溶出バルーンの世界市場レポート2020 A recently published report by QY Research titled Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also…- 周辺介入デバイスの世界市場レポート2020 Peripheral vascular devices are used for treating peripheral arterial or coronary arterial disease and also used in peripheral endovascular and coronary procedure. These devices are used to decrease the interference of patients with minimum disturbance during the surgical procedure. Market Analysis …
- 周辺介入デバイスの世界市場レポート2020 Peripheral vascular devices are used for treating peripheral arterial or coronary arterial disease and also used in peripheral endovascular and coronary procedure. These devices are used to decrease the interference of patients with minimum disturbance during the surgical procedure. Market Analysis …
- 末梢静脈血栓切除デバイスの世界市場レポート2020 A recently published report by QY Research titled Global Peripheral Venous Thrombectomy Devices Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistical…
- 経鼻ドラッグデリバリーデバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nasal Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nasal Drug Delive…